Cargando…
Poor Prognostic Factors in Surgically Resected Stage I Non-small Cell Lung Cancer: Histopathologic and Immunohistochemical Analysis
BACKGROUND: A better understanding of the histopathology and molecular biology of lung cancer might improve our capability to predict the outcome for any individual patient. The purpose of this study was to evaluate several histopathologic and molecular markers in order to assess their prognostic va...
Autores principales: | Cho, Sukki, Park, Tae In, Lee, Eung-Bae, Son, Shin-Ah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Thoracic and Cardiovascular Surgery
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322179/ https://www.ncbi.nlm.nih.gov/pubmed/22500280 http://dx.doi.org/10.5090/kjtcs.2012.45.2.101 |
Ejemplares similares
-
65. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES
por: Dankner, Matthew, et al.
Publicado: (2020) -
Impact of idiopathic pulmonary fibrosis on recurrence after surgical treatment for stage I–III non-small cell lung cancer
por: Song, Myung Jin, et al.
Publicado: (2020) -
Poorly differentiated cutaneous apocrine carcinomas: histopathological clues and immunohistochemical analysis for the diagnosis of this unusual neoplasm
por: Plaza, Jose A, et al.
Publicado: (2022) -
Prognostic Role of Circulating Tumor Cells in the Pulmonary Vein, Peripheral Blood, and Bone Marrow in Resectable Non-Small Cell Lung Cancer
por: Lee, Jeong Moon, et al.
Publicado: (2022) -
Prognostic value of an immunohistochemical signature in patients with pulmonary squamous cell carcinoma undergoing complete surgical resection
por: Lin, Chengbin, et al.
Publicado: (2022)